Literature DB >> 19624511

Prolonged bacteraemia caused by VIM-1 metallo-beta-lactamase-producing Proteus mirabilis: first report from Italy.

M Falcone1, M Perilli, M L Mezzatesta, C Mancini, G Amicosante, S Stefani, M Venditti.   

Abstract

Persistent bacteraemia arising from a case of post-operative mediastinitis as a result of a Proteus mirabilis isolate, possessing two class 1 integrons carrying bla(VIM-1) and aadA2 gene cassettes located on chromosomal and plasmidic DNA, respectively, is reported. Despite the in vitro susceptibility to carbapenems, meropenem therapy failed, whereas the patient responded to treatment with cefepime plus amikacin. To our knowledge, this is the first report of metallo-beta-lactamase production in a clinical isolate of P. mirabilis in Italy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19624511     DOI: 10.1111/j.1469-0691.2009.02781.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  4 in total

1.  Photodynamic therapy with a cationic functionalized fullerene rescues mice from fatal wound infections.

Authors:  Zongshun Lu; Tianhong Dai; Liyi Huang; Divya B Kurup; George P Tegos; Ashlee Jahnke; Tim Wharton; Michael R Hamblin
Journal:  Nanomedicine (Lond)       Date:  2010-12       Impact factor: 5.307

2.  Infections with VIM-1 metallo-{beta}-lactamase-producing enterobacter cloacae and their correlation with clinical outcome.

Authors:  Marco Falcone; Maria Lina Mezzatesta; Mariagrazia Perilli; Chiara Forcella; Alessandra Giordano; Viviana Cafiso; Gianfranco Amicosante; Stefania Stefani; Mario Venditti
Journal:  J Clin Microbiol       Date:  2009-09-09       Impact factor: 5.948

3.  VIM-1 carbapenemase-producing Escherichia coli isolated from retail seafood, Germany 2016.

Authors:  Nicole Roschanski; Sebastian Guenther; Thi Thu Tra Vu; Jennie Fischer; Torsten Semmler; Stephan Huehn; Thomas Alter; Uwe Roesler
Journal:  Euro Surveill       Date:  2017-10

4.  Undetectable Production of the VIM-1 Carbapenemase in an Atlantibacter hermannii Clinical Isolate.

Authors:  Delphine Girlich; Rémy A Bonnin; Alexis Proust; Thierry Naas; Laurent Dortet
Journal:  Front Microbiol       Date:  2021-12-20       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.